Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > MRI Contrast Agents from Viral Nanoparticles

October 5th, 2005

MRI Contrast Agents from Viral Nanoparticles

Abstract:
While other groups have used dendrimers, polymer nanoparticles, and carbon nanotubes as vehicles for gadolinium ions or iron oxide nanocrystals, a group headed by Trevor Douglas, Ph.D., and Mark Young, Ph.D., both at Montana State University, used the cowpea chlorotic mottle virus (CCMV), which infects only plants and which can be produced easily in large quantities, and the metal ion carrier. The proteins on the CCMV shell, or coat, are capable of binding as many as 180 metal atoms. In addition, other segments of these coat proteins can be used to attach molecules that could target the metal-loaded virus particles to tumors, while the empty interior of the virus particle can be used to ferry drug molecules to tumors.

Source:
nano.cancer.gov

Bookmark:

Related Links

Montana State University

Related News Press

Nanomedicine

Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013

3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013

Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013

Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013

Announcements

Sound waves precisely position nanowires June 19th, 2013

Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013

Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013

Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013